Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
Researchers from McGill University found that nurses who receive 40 minutes of bright light exposure prior to their night shifts experience less fatigue and commit fewer mistakes. Following their shifts, the nurses also slept better.
Read Full NewsAccurate and Timely Diagnosis of Endometriosis
Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors
Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity
From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes
Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities
"It really pays to be very, very, very skeptical," says one expert
Experts call for better guidance on levothyroxine initiation, deprescribing
1.
An ancient signaling pathway and 20 years of research offer hope for rare cancer
2.
New tumor therapy approach reduces costs and side effects while increasing accessibility
3.
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
4.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
5.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
1.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
2.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
3.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
4.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
5.
Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
2.
Navigating the Complexities of Ph Negative ALL - Part XIII
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge